Skip to main content
Journal cover image

LDL Particle Number and Risk of Future Cardiovascular Disease in the Framingham Offspring Study - Implications for LDL Management.

Publication ,  Journal Article
Cromwell, WC; Otvos, JD; Keyes, MJ; Pencina, MJ; Sullivan, L; Vasan, RS; Wilson, PWF; D'Agostino, RB
Published in: J Clin Lipidol
December 2007

BACKGROUND: The cholesterol content of LDL particles is variable, causing frequent discrepancies between concentrations of LDL cholesterol and LDL particle number. In managing patients at risk for cardiovascular disease (CVD) to LDL target levels, it is unclear whether LDL cholesterol provides the optimum measure of residual risk and adequacy of LDL lowering treatment. OBJECTIVE: To compare the ability of alternative measures of LDL to provide CVD risk discrimination at relatively low levels consistent with current therapeutic targets. METHODS: Concentrations of LDL cholesterol (LDL-C) and non-HDL cholesterol (non-HDL-C) were measured chemically and LDL particle number (LDL-P) and VLDL particle number (VLDL-P) were measured by nuclear magnetic resonance (NMR) in 3066 middle-aged white participants (53% women) without CVD in the Framingham Offspring cohort. The main outcome measure was incidence of first CVD event. RESULTS: At baseline, the cholesterol content per LDL particle was negatively associated with triglycerides and positively associated with LDL-C. On follow-up (median 14.8 yrs), 265 men and 266 women experienced a CVD event. In multivariable models adjusting for non-lipid CVD risk factors, LDL-P was related more strongly to future CVD in both sexes than LDL-C or non-HDL-C. Subjects with a low level of LDL-P (<25(th) percentile) had a lower CVD event rate (59 events per 1000 person-years) than those with an equivalently low level of LDL-C or non-HDL-C (81 and 74 events per 1000 person-years, respectively). CONCLUSIONS: In a large community-based sample, LDL-P was a more sensitive indicator of low CVD risk than either LDL-C or non-HDL-C, suggesting a potential clinical role for LDL-P as a goal of LDL management.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Clin Lipidol

DOI

ISSN

1933-2874

Publication Date

December 2007

Volume

1

Issue

6

Start / End Page

583 / 592

Location

United States

Related Subject Headings

  • Cardiovascular System & Hematology
  • 3205 Medical biochemistry and metabolomics
  • 3201 Cardiovascular medicine and haematology
  • 1102 Cardiorespiratory Medicine and Haematology
  • 1101 Medical Biochemistry and Metabolomics
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Cromwell, W. C., Otvos, J. D., Keyes, M. J., Pencina, M. J., Sullivan, L., Vasan, R. S., … D’Agostino, R. B. (2007). LDL Particle Number and Risk of Future Cardiovascular Disease in the Framingham Offspring Study - Implications for LDL Management. J Clin Lipidol, 1(6), 583–592. https://doi.org/10.1016/j.jacl.2007.10.001
Cromwell, William C., James D. Otvos, Michelle J. Keyes, Michael J. Pencina, Lisa Sullivan, Ramachandran S. Vasan, Peter W. F. Wilson, and Ralph B. D’Agostino. “LDL Particle Number and Risk of Future Cardiovascular Disease in the Framingham Offspring Study - Implications for LDL Management.J Clin Lipidol 1, no. 6 (December 2007): 583–92. https://doi.org/10.1016/j.jacl.2007.10.001.
Cromwell WC, Otvos JD, Keyes MJ, Pencina MJ, Sullivan L, Vasan RS, et al. LDL Particle Number and Risk of Future Cardiovascular Disease in the Framingham Offspring Study - Implications for LDL Management. J Clin Lipidol. 2007 Dec;1(6):583–92.
Cromwell, William C., et al. “LDL Particle Number and Risk of Future Cardiovascular Disease in the Framingham Offspring Study - Implications for LDL Management.J Clin Lipidol, vol. 1, no. 6, Dec. 2007, pp. 583–92. Pubmed, doi:10.1016/j.jacl.2007.10.001.
Cromwell WC, Otvos JD, Keyes MJ, Pencina MJ, Sullivan L, Vasan RS, Wilson PWF, D’Agostino RB. LDL Particle Number and Risk of Future Cardiovascular Disease in the Framingham Offspring Study - Implications for LDL Management. J Clin Lipidol. 2007 Dec;1(6):583–592.
Journal cover image

Published In

J Clin Lipidol

DOI

ISSN

1933-2874

Publication Date

December 2007

Volume

1

Issue

6

Start / End Page

583 / 592

Location

United States

Related Subject Headings

  • Cardiovascular System & Hematology
  • 3205 Medical biochemistry and metabolomics
  • 3201 Cardiovascular medicine and haematology
  • 1102 Cardiorespiratory Medicine and Haematology
  • 1101 Medical Biochemistry and Metabolomics